A recent study conducted in Dubai, UAE, has confirmed the presence of dengue virus (DENV) in Aedes aegypti mosquitoes, highlighting a growing public health concern in the region. The research, part of an enhanced mosquito surveillance program by the Dubai Municipality, involved trapping mosquitoes across various urban settings from June 2024 to June 2025. A total of 3,743 adult mosquitoes were collected, with 1,598 identified as Aedes aegypti. Notably, DENV was detected in 5 out of 151 pools of Aedes aegypti, with both DENV-1 and DENV-2 strains identified.
The significance of this finding lies in the increasing incidence of mosquito-borne diseases globally, exacerbated by climate change and urbanization. The UAE has seen a rise in dengue cases, particularly following periods of increased rainfall, which create favorable conditions for mosquito breeding. The study's results indicate that Aedes aegypti mosquitoes are now well-established in Dubai, primarily in labor camps and construction sites, raising concerns about potential outbreaks.
The research utilized advanced molecular techniques to screen for various mosquito-borne viruses, including chikungunya and Zika, but DENV was the only virus detected in the sampled Aedes aegypti. The minimum infection rate for DENV was calculated at 3.1 per 1,000 mosquitoes, with detections occurring near key urban areas, including the main Dubai airport. This underscores the need for ongoing surveillance and public health interventions to mitigate the risk of dengue transmission in the region.
As the study progresses, health authorities are urged to enhance vector control measures and public awareness campaigns to prevent potential outbreaks. The findings serve as a critical reminder of the evolving landscape of mosquito-borne diseases and the importance of proactive public health strategies in urban settings.
Emerging Inf. Dis. · 2d agoRecent findings from Slovenia highlight the emergence of Borrelia miyamotoi disease, a tick-borne illness caused by the spirochete Borrelia miyamotoi, which has been increasingly recognized as a human pathogen since its first identification in ticks in Japan in 1995. The disease has been documented in various regions across the Northern Hemisphere, including Europe, where its prevalence in Ixodes ricinus ticks is estimated to be between 1% and 4%. In Slovenia, B. miyamotoi was detected in 2% of tested ticks and small rodents, with seroprevalence studies showing antibodies in an average of 4.4% of the population.
The clinical presentation of B. miyamotoi disease typically includes acute febrile illness characterized by symptoms such as fatigue, headache, chills, myalgia, arthralgia, and nausea. Although it belongs to the relapsing fever group, recurrent febrile episodes occur in approximately 10% of cases. Notably, severe manifestations like meningoencephalitis have been reported primarily in immunocompromised individuals. As of March 2021, over 500 cases had been documented globally, with only a handful in Europe, indicating a potential underreporting of the disease in this region.
In a recent study conducted at the University Medical Centre Ljubljana, two cases of B. miyamotoi disease were confirmed through advanced metagenomic sequencing techniques. Both patients presented with acute febrile illness and were diagnosed after standard laboratory tests failed to provide a clear diagnosis. The findings underscore the importance of awareness and diagnostic capabilities for B. miyamotoi disease, particularly in areas where tick populations are prevalent. As the understanding of this pathogen evolves, healthcare professionals are urged to consider B. miyamotoi in differential diagnoses for febrile illnesses, especially in patients with recent tick exposure.
Emerging Inf. Dis. · 2d agoThe highly pathogenic avian influenza (HPAI) A(H5N1) clade 2.3.4.4b, specifically the D1.1 genotype, has shown a significant increase in prevalence across North America, particularly within the Pacific Flyway, since its initial detection in December 2021. This variant has been linked to widespread infections in wild birds, poultry, and even mammals, raising concerns about its zoonotic potential. Notably, there have been confirmed human infections, including a fatal case in Louisiana, highlighting the public health implications of this virus.
Recent surveillance efforts by the Arizona Game and Fish Department have focused on monitoring the spread of the D1.1 genotype through targeted sampling of sick or deceased birds. The findings indicate that D1.1 has become the dominant lineage among HPAI infections in both wild and domestic avian populations. Phylogenetic analyses have been employed to trace the evolutionary history and diffusion patterns of this virus, revealing critical insights into its transmission dynamics across different flyway regions.
The research utilized advanced genomic sequencing and bioinformatics tools to analyze over 660 virus genomes, providing a clearer picture of the virus's evolutionary rates and expansion timelines. The results underscore the importance of ongoing surveillance and research to understand the implications of HPAI A(H5N1) D1.1 for both animal and human health, as well as the need for preparedness in managing potential outbreaks.
As the situation evolves, continued monitoring and research will be essential to mitigate the risks associated with this highly pathogenic virus and to inform public health responses effectively.
Emerging Inf. Dis. · 2d ago